Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Tabchi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|April 21, 2017
Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized MedicineSamer Tabchi, Normand Blais
Current Opinion in Oncology|May 4, 2016
Immune-mediated respiratory adverse events of checkpoint inhibitorsSamer Tabchi, Christine Messier, Normand Blais
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumabSamer Tabchi, Xiaoduan Weng, Normand Blais
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 2, 2016
Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational AnalysisElie Kassouf, Samer Tabchi, Mustapha Tehfe
World Journal of Gastroenterology|May 24, 2017
Checkpoint inhibitors in gastrointestinal cancers: Expectations and realityHampig Raphael Kourie, Samer Tabchi, Marwan Ghosn
Investigational New Drugs|August 27, 2016
Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategySamer Tabchi, Hampig Raphael Kourie, Joseph Kattan
Current Opinion in Oncology|December 28, 2016
Concurrent driver mutations/rearrangements in non-small-cell lung cancerSamer Tabchi, Hampig R Kourie, Jean Klastersky
World Journal of Gastroenterology|August 1, 2015
Gastrointestinal cancers in the era of theranostics: Updates and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi
World Journal of Gastroenterology|March 23, 2016
Metastatic gastric cancer treatment: Second line and beyondMarwan Ghosn, Samer Tabchi, Hampig Raphael Kourie, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2017
Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancerSamer Tabchi, Normand Blais, Marie-Pierre Campeau, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|April 21, 2017
Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized MedicineSamer Tabchi, Normand Blais
Current Opinion in Oncology|May 4, 2016
Immune-mediated respiratory adverse events of checkpoint inhibitorsSamer Tabchi, Christine Messier, Normand Blais
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumabSamer Tabchi, Xiaoduan Weng, Normand Blais
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 2, 2016
Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational AnalysisElie Kassouf, Samer Tabchi, Mustapha Tehfe
World Journal of Gastroenterology|May 24, 2017
Checkpoint inhibitors in gastrointestinal cancers: Expectations and realityHampig Raphael Kourie, Samer Tabchi, Marwan Ghosn
Investigational New Drugs|August 27, 2016
Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategySamer Tabchi, Hampig Raphael Kourie, Joseph Kattan
Current Opinion in Oncology|December 28, 2016
Concurrent driver mutations/rearrangements in non-small-cell lung cancerSamer Tabchi, Hampig R Kourie, Jean Klastersky
World Journal of Gastroenterology|August 1, 2015
Gastrointestinal cancers in the era of theranostics: Updates and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi
World Journal of Gastroenterology|March 23, 2016
Metastatic gastric cancer treatment: Second line and beyondMarwan Ghosn, Samer Tabchi, Hampig Raphael Kourie, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2017
Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancerSamer Tabchi, Normand Blais, Marie-Pierre Campeau, et al.
Pageof 3